Background-Ischaemialreperfusion (I/R) of the intestine causes mucosal injury associated with a high death rate in rats. Aim-To investigate whether nitric oxide (NO) might be implicated in the recovery of the intestinal mucosa after ischaemic insult. Methods-Wistar rats were subjected to mesenteric artery occlusion for 90 minutes. The animals were given either L-arginine, the substrate of NO synthase, or molsidomine, a NO donor. The controls received casein hydrolysate. The compounds were administered by gavage 19, 16, and 1.5 hours before ischaemia. Mucosal barrier permeability and cGMP content were determined 24 hours after ischaemia.
It has clearly been shown in animals that morphological and functional injury of the intestinal mucosa occurs during ischaemia and is exacerbated after re-establishment of tissue perfusion.' This injury includes mucosal barrier disruption leading to increased mucosal and vascular permeability, bacterial translocation, and a high death rate.24 It has been proposed that most of the mucosal injury resulting from ischaemia/reperfusion (I/R) is mediated by production and release of reactive oxygen derived free radicals when hypoxic tissues are reoxygenated during reperfusion.5
Mucosal functions are spontaneously restored within hours or days during reperfusion depending on the duration and the severity of the mesenteric ischaemic period.6 7 Little is known about the mechanisms that contribute to the recovery of intestinal mucosal integrity after ischaemic insult. Several approaches have been used to reduce I/R injury of the intestinal mucosa and to accelerate regeneration of mucosal functions after IIR. Among these are administration of free radical scavengers,8 9 inhibition of xanthine oxidase,'0 neutrophil depletion,"1 12 inhibition of leucocyte endothelial adherence,9 13 administration of platelet activating factor (PAF) antagonists,'4 intraluminal oxygenation.'5 A study performed in our laboratory showed that pretreatment with L-arginine accelerated the recovery of intestinal morphology and hydrolase activities after ischaemic insult in rats. '6 These results suggest that NO might participate in the recovery of mucosal function after IYR. This conclusion is consistent with the data reporting that administration of exogenous sources of NO during I/R protects against mucosal barrier dysfunction4 17 and with data demonstrating that the inhibition of NO production exacerbates intestinal damage induced by endotoxic shock'8 or PAF. '9 The objective of this study was to extend the possible contribution of NO in the regeneration of mucosal function by examining the effects of NO on intestinal barrier permeability in the postischaemic intestine. This was accomplished by determining the effect of enteral pretreatment with the NO precursor Larginine, the anti-anginal drug and NO donor molsidomine, and the NO biosynthesis inhibitor L-NAME, on intestinal lumen to blood fluxes of labelled polyethylene glycol 4000 (14C-PEG).
As NO activates guanylate cyclase and increases cGMP formation,20 which mainly account for the NO effects,2' we determined intestinal mucosal cGMP content. As an index of intestinal function, we measured hydrolase activities in the mucosa.
Methods

Animals
Male Wistar rats weighing 360-430 g (Laboratoires Janvier, France) and fed a standard diet (A04 from UAR, Villemoisson/Orge, France) were used. The animals were deprived of food 24 hours before surgery and during the whole experiment but were allowed free access to drinking water. The animals were assigned to one of the four groups: (1) casein-I/R (control) rats were given casein hydrolysate (0.8 g/kg wt), (2) L-arginine-I/R rats were given L-arginine, the substrate ofNO (0-8 g/kg wt), (3) molsidomine-IIR rats were given molsidomine, a NO donor (12 mg/kg wt) at a dose expected to result in similar haemodynamic effects to L-arginine (R Henning, personal communication), and (4) L-NAME-I/R rats were given NG-nitro-L-arginine methyl ester (L-NAME), an inhibitor of NO biosynthesis (50 mg/kg wt).
An additional group of sham operated rats were given casein hydrolysate but were not subjected to ischaemia.
Compounds were administered by gavage 19, 16, and 1.5 hours before sham surgery or ischaemia.
Ischaemia procedure The rats were anaesthetised by intraperitoneal injection of ketamine (Imalgene 1000, 150 ,u/100 g wt). After induction of anaesthesia, the rats underwent midline laparatomy and the intestine was exposed. Inferior mesenteric artery was isolated near its aortic origin and occluded with an arterial bulldog clamp. Collateral blood flow interruption was achieved by ligating the right colonic artery and the jejunal arcades just proximal to the point of the mesenteric artery occlusion as described by Megison et al.22 In the sham operated rats, the mesenteric artery and collateral vessels were isolated in a similar fashion but not occluded. The intestine was replaced into the peritoneal cavity for the duration of ischaemic period. The animals were placed under a heating lamp to maintain body temperature at 37°C. After 90 minutes, the arterial clamp was removed and the abdomen closed. The animals were then placed in plastic cages and mortality observed for each group.
Determination of mucosal permeability Permeability of the mucosal barrier was assessed by measuring the lumen to blood fluxes of 14C-PEG using a modification of the technique described by Winne and Gorig.23 Briefly, 24 hours after the beginning of intestinal reperfusion the rats were anaesthetised by intraperitoneal injection of ethyl carbamate (1 ml/100 g wt). A catheter was inserted into the left jugular vein. The intestine was then exposed after a midline laparotomy. The in situ length of the jejunoileum was measured using a thread placed along its curved axis. The jejunoileum was cross sectioned in its middle and a 5 cm length segment just above the section was ligated at the two extremities with a thread. The rat was then placed into a box, which was kept at 37°C and dampened by circulating water. The exposed intestinal segment was covered with saline soaked gauze to prevent dessication. Heparin (600 U/kg wt) was then injected through the jugular vein. The mesenteric vein draining the isolated intestinal segment was cannulated (Polyethylene Biotrol 0 96/0.58 mm). To collect only the venous blood from the isolated intestinal segment, the main mesenteric vein below the segment was ligated as well as the collateral veins. The venous effluent was allowed to drain freely and was collected at intervals of two minutes into 2 ml calibrated tubes. The blood loss was compensated by jugular infusion of fresh heparinised rat blood. After stabilisation of the mesenteric venous flow rate the isolated intestinal segment was intraluminally injected with 0.5 ml of Krebs-Ringer solution containing '4C-PEG (for composition see below). The blood samples were centrifugated and the plasma 14C-PEG activity quantified by liquid scintillation counting. In all rats the time course of plasma 14C-PEG concentration showed a plateau within six to eight minutes after the beginning of blood collection (data not shown). For (Fig  1) . All animals (six of six) in the L-NAME-IIR group died between six to 24 hours after the onset of reperfusion.
Mesenteric venous bloodflow Baseline mesenteric venous blood flow rates (VBFR) in the L-arginine-I/R and molsidomine-I/R groups were higher compared with casein-I/R group (Fig 2) . VBFR values in the L-arginine-IVR and molsidomine-I/R groups were not different from that obtained in the sham group (0.27 (0.05) ml/min, n=4).
Intestinal barrier permeability The intestinal barrier permeability, as measured by 14C-PEG absorption, for the three groups is shown in Figure 3 . Animals Figure 4 illustrates the mucosal content of cGMP. In the L-arginine-I/R group, the mucosal cGMP content was significantly higher than in casein-IIR and molsidomine-I/R groups.
Discussion
These data show that enteral pretreatment with L-arginine, the substrate of NO, or molsidomine, a NO donor, improved survival and accelerated the recovery of the intestinal barrier function of the VR injured mucosa. We present evidence that NO is responsible for these effects. This hypothesis is further supported by the fact that pretreatment with L-NAME, the well known inhibitor of NO biosynthesis, increased mortality (in this study) and exacerbated mucosal damages occurring after intestinal IR. 16 ity was reduced by 50% three and four hours of ie beneficial reperfusion, whereas Ca2+ independent NOS *arginine and activity was undetectable. These data suggest r of normal that mucosal dysfunction may be attributed to t of the ability the inhibition of cNOS activity rather to iNOS. nt the reducIn a study performed under the same expersociated with imental conditions, we have shown that rats nic intestine. pretreated with L-arginine exhibited by four ng that NO hours of reperfusion a better morphological 1 3234 support recovery of the intestinal mucosa and higher cogenous NO hydrolase activities than controls receiving properties in casein hydrolysate.'6 These data showed that ia preventing by 24 hours of reperfusion, sucrase and aminopeptidase activities were similar in mucosa from casein, L-arginine, and molsidomine pretreated animals. This finding suggest that mucosal hydrolase activities recover faster than mucosal permeability after VR.
These data show that exogenous sources of NO (L-arginine and molsidomine) given enterally before ischaemia improved survival and intestinal mucosal barrier function. We speculate that increasing NO formation or provision of exogenous NO may exert a beneficial effect by improving intestinal recovery from ischaemic insult.
